Fig. 5From: Comprehensive analysis identifies CLEC1B as a potential prognostic biomarker in hepatocellular carcinomaImmunological correlation and GSEA of CLEC1B. (A) Correlation analysis between CLEC1B expression and 122 types of immunomodulators. (B) GSEA of CLEC1B based on the hallmarks gene set. (C, D) Association between CLEC1B expression and immune subtypes. *P-value < 0.05Back to article page